NeoGenomics (NEO) Releases FY 2019 Earnings Guidance

   2019-05-01 02:05

NeoGenomics (NASDAQ:NEO) updated its FY 2019 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of $0.23-0.27 for the period, compared to the Thomson Reuters consensus estimate of $0.24. The company issued revenue guidance of $384-400 million, compared to the consensus revenue estimate of $385.07.

Several research firms have issued reports on NEO. BidaskClub downgraded shares of NeoGenomics from a strong-buy rating to a buy rating in a report on Thursday, April 18th. Zacks Investment Research raised shares of NeoGenomics from a hold rating to a buy rating and set a $22.00 price objective on the stock in a report on Tuesday, March 5th. Needham & Company LLC increased their price objective on shares of NeoGenomics from $19.00 to $22.00 and gave the company a buy rating in a report on Friday, March 29th. ValuEngine raised shares of NeoGenomics from a buy rating to a strong-buy rating in a report on Thursday, January 10th. Finally, CIBC raised shares of NeoGenomics from a neutral rating to an outperform rating and decreased their price objective for the company from $18.00 to $15.00 in a report on Tuesday, March 12th. One investment analyst has rated the stock with a hold rating, eleven have issued a buy rating and one has given a strong buy rating to the company. The stock presently has an average rating of Buy and a consensus target price of $19.55.



Shares of NASDAQ:NEO traded down $0.06 during midday trading on Tuesday, hitting $20.83. The company’s stock had a trading volume of 1,205,496 shares, compared to its average volume of 1,174,718. The company has a current ratio of 1.70, a quick ratio of 1.56 and a debt-to-equity ratio of 0.31. The company has a market cap of $1.99 billion, a P/E ratio of 159.46 and a beta of 0.93. NeoGenomics has a 12-month low of $9.49 and a 12-month high of $22.17.

NeoGenomics (NASDAQ:NEO) last posted its quarterly earnings results on Tuesday, February 19th. The medical research company reported $0.06 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.04 by $0.02. The firm had revenue of $76.50 million for the quarter, compared to the consensus estimate of $71.29 million. NeoGenomics had a net margin of 0.95% and a return on equity of 2.25%. The company’s revenue for the quarter was up 24.6% on a year-over-year basis. During the same period last year, the firm posted $0.05 earnings per share. On average, analysts expect that NeoGenomics will post 0.18 earnings per share for the current year.

In other NeoGenomics news, VP Jennifer Balliet sold 14,000 shares of NeoGenomics stock in a transaction dated Monday, March 4th. The shares were sold at an average price of $19.09, for a total transaction of $267,260.00. Following the transaction, the vice president now directly owns 40,000 shares of the company’s stock, valued at $763,600. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Steven C. Jones sold 14,621 shares of NeoGenomics stock in a transaction dated Tuesday, February 26th. The stock was sold at an average price of $19.24, for a total transaction of $281,308.04. Following the transaction, the executive vice president now directly owns 241,815 shares in the company, valued at $4,652,520.60. The disclosure for this sale can be found here. Over the last three months, insiders sold 263,524 shares of company stock worth $5,019,496. Insiders own 12.20% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “NeoGenomics (NEO) Releases FY 2019 Earnings Guidance” was first reported by Daily Political and is the property of of Daily Political. If you are accessing this piece of content on another domain, it was stolen and republished in violation of international copyright & trademark legislation. The original version of this piece of content can be accessed at https://www.dailypolitical.com/2019/04/30/neogenomics-neo-releases-fy-2019-earnings-guidance.html.

NeoGenomics Company Profile

NeoGenomics, Inc, together with its subsidiaries, operates a network of cancer-focused genetic testing laboratories in the United States; and laboratories in Switzerland and Singapore. It operates in two segments, Clinical Services and Pharma Services. The company’s laboratories provide genetic and molecular testing services to hospitals, pathologists, oncologists, urologists, other clinicians and researchers, pharmaceutical firms, academic centers, and other clinical laboratories.

Featured Story: What is a stock buyback?

Earnings History and Estimates for NeoGenomics (NASDAQ:NEO)

Receive News & Ratings for NeoGenomics Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for NeoGenomics and related companies with MarketBeat.com’s FREE daily email newsletter.


Original Source



Warning: array_key_exists() expects parameter 2 to be array, null given in /home/coinbloc/public_html/wp-content/plugins/virtual_coin_widgets/includes/data.php on line 34

Warning: array_key_exists() expects parameter 2 to be array, null given in /home/coinbloc/public_html/wp-content/plugins/virtual_coin_widgets/includes/data.php on line 34

Warning: array_key_exists() expects parameter 2 to be array, null given in /home/coinbloc/public_html/wp-content/plugins/virtual_coin_widgets/includes/data.php on line 34

Warning: array_key_exists() expects parameter 2 to be array, null given in /home/coinbloc/public_html/wp-content/plugins/virtual_coin_widgets/includes/data.php on line 34

Warning: array_key_exists() expects parameter 2 to be array, null given in /home/coinbloc/public_html/wp-content/plugins/virtual_coin_widgets/includes/data.php on line 34

Warning: array_key_exists() expects parameter 2 to be array, null given in /home/coinbloc/public_html/wp-content/plugins/virtual_coin_widgets/includes/data.php on line 34

Warning: array_key_exists() expects parameter 2 to be array, null given in /home/coinbloc/public_html/wp-content/plugins/virtual_coin_widgets/includes/data.php on line 34
CryptoCurrencyUSDChange 1hChange 24hChange 7d
? --- 0.00 % 0.00 %
? --- 0.00 % 0.00 %
? --- 0.00 % 0.00 %
? --- 0.00 % 0.00 %
? --- 0.00 % 0.00 %
? --- 0.00 % 0.00 %
? --- 0.00 % 0.00 %
? --- 0.00 % 0.00 %
? --- 0.00 % 0.00 %
? --- 0.00 % 0.00 %
? --- 0.00 % 0.00 %
? --- 0.00 % 0.00 %
? --- 0.00 % 0.00 %
? --- 0.00 % 0.00 %
? --- 0.00 % 0.00 %
? --- 0.00 % 0.00 %
? --- 0.00 % 0.00 %
? --- 0.00 % 0.00 %
? --- 0.00 % 0.00 %
? --- 0.00 % 0.00 %